Correction: Safety, tolerability, and concordance with interferon-gamma release assays of a recombinant ESAT6-MPT64 skin test: a phase 1 randomized clinical trial

Front Immunol. 2026 Apr 29;17:1863033. doi: 10.3389/fimmu.2026.1863033. eCollection 2026.

ABSTRACT

[This corrects the article DOI: 10.3389/fimmu.2026.1780294.].